Respiratory Viral Infection clinical trials at University of California Health
1 research study open to eligible people
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness
open to eligible people ages 18-65
Open label clinical trial of healthy persons (adults) who will receive the diet supplement oral mitoquinone/mitoquinol mesylate (Mito-MES) to prevent the development and progression of severe viral infections like COVID-19 after high-risk exposure to a person with possible respiratory viral infection such as SARS-CoV-2 infection.
Our lead scientists for Respiratory Viral Infection research studies include Theodoros Kelesidis, MD PHD.